HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Laura J MahadyM NadeemM Malek-AhmadiK ChenS E PerezElliott J MufsonPublished in: Neuropathology and applied neurobiology (2018)
These findings suggest that HDAC2 dysregulation contributes to cholinergic nbM neuronal dysfunction, NFT pathology, and cognitive decline during clinical progression of AD.